نتائج البحث

FDA New Drug Application Accepted for Sebetralstat to Treat Hereditary Angioedema.

• Authors : Lutton, Logan

Subjects: UNITED States. Food & Drug Administration; ORAL drug administration; TREATMENT duration

• Source: Formulary Watch. 9/3/2024, p1-1. 1p.

تفاصيل العنوان

New drug application is submitted for novel oral TRT for hypogonadism.

• Authors : BRODERICK, JASON M.

Subjects: *THERAPEUTIC use of testosterone; *HYPOGONADISM; *TESTOSTERONE

• Source: Urology Times. Feb2021, Vol. 49 Issue 2, p7-7. 1/4p.

تفاصيل العنوان

FDA ACCEPTS NEW DRUG APPLICATION FOR OVERACTIVE BLADDER AGENT.

Subjects: *DRUG approval; *OVERACTIVE bladderUNITED States. Food & Drug Administration

• Source: Urology Times. Mar2020, Vol. 48 Issue 3, p7-7. 1/6p.

تفاصيل العنوان

FDA approves new drug application for difluprednate 0.05%.

• Authors : Groves, Nancy

Subjects: PHARMACEUTICAL research; KORENFELD, Michael S.; SIRION Therapeutics Inc.UNITED States

• Source: Ophthalmology Times. 7/15/2008, Vol. 33 Issue 14, p1-11. 3p.

تفاصيل العنوان

FDA CLEARS NEW DRUG APPLICATION FOR TOPICAL PSORIASIS TREATMENT.

Subjects: COMBINATION drug therapy; PSORIASIS; CUTANEOUS therapeutics

• Source: Dermatology Times. Feb2018, Vol. 39 Issue 2, p14-14. 2/3p.

تفاصيل العنوان

New drug application: FDA grants priority review to fluocinolone for DME.

Subjects: ALIMERA Sciences Inc.; PHARMACEUTICAL research; DIABETES

• Source: Ophthalmology Times. 10/1/2010, Vol. 35 Issue 19, p12-12. 1/5p.

تفاصيل العنوان

New drug application filed for Retin-A formulation.

Subjects: PATENT law; TRETINOIN; HERON Therapeutics Inc.UNITED States

• Source: Dermatology Times. Nov2001 Supplement, Vol. 22 Issue 11, pS6. 1/4p.

تفاصيل العنوان

Shire to submit new drug application to FDA for dry eye disease.

• Source: Optometry Times. Jun2014, Vol. 6 Issue 6, p6-6. 1/4p.

تفاصيل العنوان

FDA Sets Goal Date for Ovarian Cancer Combination.

• Source: Formulary Watch. 1/2/2025, p2-2. 1p.

تفاصيل العنوان

ICER: Potential New Pain Medication Offers Small Savings.

• Authors : Myshko, Denise

Subjects: SUBSTANCE abuse prevention; COST control; PATIENT safety

• Source: Formulary Watch. 12/9/2024, p1-1. 1p.

تفاصيل العنوان